在服用全身氨酸激酶抑制剂的患者中,有视网膜静脉封闭的风险
Nitesh Mohan1,2, Sunil K Srivastava1, Chandni Duphare1
1Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA.
Eye (London, England)
|February 6, 2026
概括
这项研究发现,氨酸激酶抑制剂 (TKI) 治疗与视网膜静脉封闭 (RVO) 之间存在可能的联系. 接受TKI治疗的患者,特别是患有血管风险因素的患者,需要对RVO发育进行仔细监测.
科学领域:
- 眼科医生 眼科 眼科
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 氨酸激酶抑制剂 (TKI) 在治疗系统性恶性瘤方面至关重要.
- 视网膜静脉封闭 (RVO) 是一种严重的眼血管事件.
- 技术知识产权的潜在眼部副作用需要调查.
研究的目的:
- 为了调查在接受TKI治疗癌症的患者中RVO的发生情况.
- 在这个患者队列中确定RVO的特征和结果.
主要方法:
- 从2014年至2024年期间接受TCI治疗的患者的回顾性图表审查.
- 数据收集包括人口统计,癌症类型,TKI细节,眼科病史和结果.
- 对眼科成像进行了审查,以确认RVO诊断.
主要成果:
- 在TKI治疗期间,11名患者 (12只眼睛) 发生RVO.
- 常见的TKI包括伊马替尼,阿克西替尼,易布鲁替尼和雷戈拉费尼.
- 纳兰乔平均得分表明TKI使用和RVO之间可能存在关联.
结论:
- 在TKI治疗和RVO的发展之间存在潜在的关联.
- 提高对TKIs患者的认识至关重要,特别是那些患有血管风险因素的患者.
相关概念视频
Receptor Tyrosine Kinases
18.9K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.9K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
550
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
550
Overview of Systemic Veins
1.3K
Systemic veins are crucial blood vessels that return deoxygenated blood from various body tissues back to the heart. There are three systemic veins that return deoxygenated blood to the heart, they are as follows.
The coronary sinus, the heart's principal vein, resides in the coronary sulcus on the heart's posterior aspect. This broad venous channel receives nearly all venous blood from the myocardium, the heart muscle. It is fed by three primary veins: the great cardiac vein, the...
The coronary sinus, the heart's principal vein, resides in the coronary sulcus on the heart's posterior aspect. This broad venous channel receives nearly all venous blood from the myocardium, the heart muscle. It is fed by three primary veins: the great cardiac vein, the...
1.3K
Protein Kinases and Phosphatases
15.2K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
Protein Kinases and Phosphatases
4.5K
4.5K
Eukaryotic Transcription Inhibitors
11.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K


